Henry A, Pieters BR, André Siebert F, Hoskin P; UROGEC group of GEC ESTRO with endorsement by the European Association of Urology.
Radiother Oncol. 2022 Feb;167:244-251. doi: 10.1016/j.radonc.2021.12.047. Epub 2022 Jan 6.
PMID:34999134
Absorbed dose calorimetry.
Renaud J, Palmans H, Sarfehnia A, Seuntjens J.
Phys Med Biol. 2020 Mar 2;65(5):05TR02. doi: 10.1088/1361-6560/ab4f29.
PMID:31627202
Benchmark IMRT evaluation of a Co-60 MRI-guided radiation therapy system.
Wooten HO, Rodriguez V, Green O, Kashani R, Santanam L, Tanderup K, Mutic S, Li HH.
Radiother Oncol. 2015 Mar;114(3):402-5. doi: 10.1016/j.radonc.2015.01.015. Epub 2015 Mar 4.
PMID:25746353
A comparative planning study for lung SABR between tri-Co-60 magnetic resonance image guided radiation therapy system and volumetric modulated arc therapy.
Park JM, Park SY, Kim HJ, Wu HG, Carlson J, Kim JI.
A comparison of treatment plan quality between Tri-Co-60 intensity modulated radiation therapy and volumetric modulated arc therapy for cervical cancer.
Hybrid Tri-Co-60 MRI radiotherapy for locally advanced rectal cancer: An in silico evaluation.
Boldrini L, Placidi E, Dinapoli N, Azario L, Cellini F, Massaccesi M, Chiesa S, Gambacorta MA, Mattiucci GC, Piccari D, Teodoli S, De Spirito M, Valentini V.
Tech Innov Patient Support Radiat Oncol. 2018 Mar 31;6:5-10. doi: 10.1016/j.tipsro.2018.02.002. eCollection 2018 Jun.
PMID:32095572
Treatment plan comparison between Tri-Co-60 magnetic-resonance image-guided radiation therapy and volumetric modulated arc therapy for prostate cancer.
Park JM, Park SY, Choi CH, Chun M, Kim JH, Kim JI.
Oncotarget. 2017 Aug 8;8(53):91174-91184. doi: 10.18632/oncotarget.20039. eCollection 2017 Oct 31.